Pointing out the blindingly obvious is not scaremongering. The...

Pointing out the blindingly obvious is not scaremongering.

The company has run down its cash and is now in a weakened position in negotiations for any deal.

A cap raise is needed.

And if you had not noticed, Merck's backing of Bionomics has not made any of us rich so far despite years of unfailing patronage.

Merck is in it for what Merck can get out of it.

They owe us no favors but have the whip hand in any future deals.

Stop kidding yourselves and painting me as a scaremonger.

If everything was hunky dory, the shares would not be at 48c.

One lone poster on an unwatched HC thread has not depressed the price - others have voted with their feet too.

Did you not notice that one of the biggest holders has flogged possibly 10m shares and driven the price from circa 60c to where it currently sits.

Don't blame me big boy.

The company needs a rocket whether you acknowledge that or not.

They have had long enough to deliver shareholders a return and unless these results are spectacular, we will all be wondering what all the excitement was about.....................

Good luck to all.